ArticleOphthalmology science2026
In-Context Learning for Data-Efficient Diabetic Retinopathy Detection via Multimodal Foundation Models.
Article in Ophthalmology science, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
4 citing papers in PubMed.
- A systematic review on deep learning techniques for diabetic retinopathy classification in retinal fundus images.iScience · 2026Article
- Explicit Inclusion of Diabetes Mellitus Without Retinopathy Within Diabetic Retinopathy Prediction.Translational vision science & technology · 2026Article
- Comparative Analysis of General-Purpose vs. Domain-Specific Multimodal Models for Diabetic Retinopathy Classification.Diagnostics (Basel, Switzerland) · 2026Article
- Artificial intelligence-powered prediction of diabetic complications: from clinical data to molecular omics.Briefings in bioinformatics · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Objective: This study aims to evaluate whether in-context learning (ICL), a prompt-based learning mechanism enabling multimodal foundation models to rapidly adapt to new tasks without retraining or large annotated datasets, can achieve comparable diagnostic performance to domain-specific foundation models. Specifically, we use diabetic retinopathy (DR) detection as an exemplar task to probe if a multimodal foundation model (Google Gemini 1.5 Pro), employing ICL, can match the performance of a domain-specific model (RETFound) fine-tuned explicitly for DR detection from color fundus photographs (CFPs). Design: A cross-sectional study. Subjects: A retrospective, publicly available dataset (Indian Diabetic Retinopathy Image Dataset) comprising 516 CFPs collected at an eye clinic in India, featuring both healthy individuals and patients with DR. Methods: The images were dichotomized into 2 groups based on the presence or absence of any signs of DR. RETFound was fine-tuned for this binary classification task, while Gemini 1.5 Pro was assessed for it under zero-shot and few-shot prompting scenarios, with the latter incorporating random or k-nearest-neighbors-based sampling of a varying number of example images. For experiments, data were partitioned into training, validation, and test sets in a stratified manner, with the process repeated for 10-fold cross-validation. Main Outcome Measures: Performance was assessed via accuracy, F1 score, and expected calibration error of predictive probabilities. Statistical significance was evaluated using Wilcoxon tests. Results: The best ICL performance with Gemini 1.5 Pro yielded an average accuracy of 0.841 (95% confidence interval [CI]: 0.803-0.879), an F1 score of 0.876 (95% CI: 0.844-0.909), and a calibration error of 0.129 (95% CI: 0.107-0.152). RETFound achieved an average accuracy of 0.849 (95% CI: 0.813-0.885), an F1 score of 0.883 (95% CI: 0.852-0.915), and a calibration error of 0.081 (95% CI: 0.066-0.097). While accuracy and F1 scores were comparable ( Conclusions: Gemini 1.5 Pro with ICL demonstrated performance comparable to RETFound for binary DR detection, illustrating how future medical artificial intelligence systems may build upon such frontier models rather than being bespoke solutions. Financial Disclosures: Proprietary or commercial disclosure may be found in the Footnotes and Disclosures at the end of this article.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.